Altria MO
- Market cap
- $124.1B
- PE
- 15.7×
- 10y median 13.1×
- Forward PE
- 12.9×
- 10y median 10.7×
- Price to sales
- 6.1×
- EV/EBIT
- 12.9×
- Revenue, 12 months
- $20.4B
- +1% on a year ago
- Net margin
- 39.0%
- Free cash flow yield
- 7.3%
Altria trades at 15.7× trailing earnings, pricier than 65% of the last ten years. Revenue was $20.4B over the last twelve months, up 1% on a year earlier with a 39% net margin.
Charts
Financials
| Income statement | Q3 FY23 | Q4 FY23 | Q1 FY24 | Q2 FY24 | Q3 FY24 | Q4 FY24 | Q1 FY25 | Q2 FY25 | Q3 FY25 | Q4 FY25 | Q1 FY26 | Q2 FY26 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| $5.3B−3% | $5B−1% | $4.7B−1% | $5.3B−3% | $5.3B+1% | $5.1B+2% | $4.5B−4% | $5.3B+0% | $5.3B−2% | $5.1B−1% | $4.8B+5% | $5.4B+1% | |
| Cost of revenue | $1.6B−8% | $1.5B−3% | $1.4B+0% | $1.6B−5% | $1.5B−3% | $1.5B−2% | $1.3B−12% | $1.4B−10% | $1.4B−6% | $1.4B−4% | $1.3B−1% | $1.5B+7% |
| Gross profit | $3.7B+0% | $3.5B−0% | $3.3B−2% | $3.7B−2% | $3.8B+3% | $3.6B+3% | $3.2B−1% | $3.9B+5% | $3.8B+0% | $3.6B+1% | $3.5B+8% | $3.8B−1% |
| SG&A | $610M+4% | $703M+2% | $606M+6% | $788M−8% | $656M+8% | $687M−2% | $588M−3% | $619M−21% | $580M−12% | $720M+5% | $550M−7% | $663M+7% |
| $3.1B−1% | $2.8B−1% | $2.7B−3% | $2.5B−13% | $3.2B+2% | $2.9B+3% | $1.8B−33% | $3.2B+28% | $3.2B+3% | $1.7B−43% | $3B+65% | $3.1B−3% | |
| Pre-tax income | $2.9B+615% | $2.7B+1% | $2.7B+11% | $5.1B+82% | $3B+4% | $2.8B+2% | $1.7B−39% | $3.1B−39% | $3.1B+2% | $1.5B−46% | $2.9B+70% | $2.9B−6% |
| $742M+306% | $675M+4721% | $610M−12% | $1.3B+91% | $733M−1% | −$262M | $606M−1% | $740M−44% | $700M−5% | $396M | $676M+12% | $631M−15% | |
| Net income | $2.2B+867% | $2.1B−23% | $2.1B+19% | $3.8B+80% | $2.3B+6% | $3B+48% | $1.1B−49% | $2.4B−38% | $2.4B+4% | $1.1B−63% | $2.2B+103% | $2.3B−3% |
| $1.22+917% | $1.16−23% | $1.21+21% | $2.21+86% | $1.34+10% | $1.79+54% | $0.63−48% | $1.41−36% | $1.41+5% | $0.66−63% | $1.30+106% | $1.37−3% | |
| 1.8B−1% | 1.8B−1% | 1.8B−2% | 1.7B−4% | 1.7B−4% | 1.7B−4% | 1.7B−4% | 1.7B−2% | 1.7B−1% | 1.7B−1% | 1.7B−1% | 1.7B−1% |
EPS, diluted: 7 periods, Q4 FY09 to Q4 FY25: quarter's net income to common over its shares, to the cent.
Diluted shares: 15 periods, Q4 FY09 to Q4 FY25: share-days: the 12-month average less the 9-month, weighted by days. Q4 FY18: the earlier year to date counted no dilution: the quarter's basic count plus the later year to date's dilution. Q4 FY19: a loss quarter: its basic count, share-days: the 12-month average less the 9-month, weighted by days.
From each company's 10-Q and 10-K filings, the newest version of each figure. Quarters are as filed (a fourth quarter is the year less its first nine months), fiscal years as the 10-K prints them, restated where a later 10-K restated them, and balance sheet lines as of the period's end. A quarter whose 10-Q isn't filed yet is from the company's results release. Growth is on the same period a year earlier. A dash is a period with no figure for the line: the filing doesn't print it, or it hasn't been read yet.
Estimates
Next earnings report: .
| Quarter | Revenue | Range | EPS | Range | Analysts |
|---|---|---|---|---|---|
| Q3 FY26 | $5.3B | $5.2B to $5.4B | $1.51 | $1.48 to $1.53 | 8 |
| Q4 FY26 | $5.1B | $5B to $5.1B | $1.37 | $1.31 to $1.46 | 7 |
| Q1 FY27 | $4.7B | $4.7B to $4.8B | $1.36 | $1.32 to $1.38 | 2 |
| Q2 FY27 | $5.4B | $5.3B to $5.4B | $1.53 | $1.50 to $1.56 | 2 |
| Q3 FY27 | $5.4B | $5.3B to $5.5B | $1.57 | $1.53 to $1.60 | 2 |
| Q4 FY27 | $5.2B | $5.1B to $5.2B | $1.43 | $1.39 to $1.45 | 5 |
| Q1 FY28 | $4.9B | $4.8B to $4.9B | $1.42 | $1.38 to $1.44 | 6 |
| Q2 FY28 | $5.5B | $5.4B to $5.6B | $1.60 | $1.56 to $1.63 | 5 |
Peers
Companies in Consumer Defensive nearest Altria's size, closest first.
| Company | Market cap | PE | Its 10y median PE | Fwd PE | P/S | Revenue growth | Net margin |
|---|---|---|---|---|---|---|---|
| MOAltria | $124.1B | 15.7× | 13.1× | 12.9× | 6.1× | +1% | 39.0% |
| MNSTMonster Beverage | $90.5B | 42.8× | 37.9× | 37.4× | 9.8× | +20% | 23.1% |
| PEPPepsiCo | $185B | 17.1× | 25.9× | 16.0× | 1.9× | +6% | 11.1% |
| MDLZMondelez International | $81.4B | 23.5× | 22.6× | 19.8× | 2.1× | +7% | 8.9% |
| CLColgate-Palmolive | $75B | 37.3× | 27.2× | 24.0× | 3.6× | +5% | 9.7% |
| TGTTarget | $69.4B | 15.9× | 15.8× | 16.5× | 0.6× | +2% | 4.1% |
| PMPhilip Morris International | $310.9B | 29.1× | 18.5× | 22.2× | 7.2× | +8% | 24.8% |
| KDPKeurig Dr Pepper | $47.2B | 35.0× | 25.9× | 14.2× | 2.3× | +27% | 7.1% |
| PGProcter & Gamble | $374.3B | 24.3× | 25.2× | 23.3× | 4.3× | +4% | 18.2% |
| KRKroger | $39.4B | 36.1× | 15.7× | 12.5× | 0.3× | +2% | 0.7% |
| ELEstée Lauder Companies | $39.3B | 222× | 44.6× | 32.8× | 2.6× | +5% | 1.2% |
| Peer median | $78.2B | 32.1× | 25.5× | 21.0× | 2.5× | +6% | 9.3% |
Investors who own it
Investors we follow who held Altria at the end of Jun 30, 2026, from their 13F filings.
- Tom RussoGardner Russo & Quinn0.1% of portfoliotrimmed
- Lee AinslieMaverick Capital0.0% of portfoliotrimmed
More on Altria
Each number over time
- PE ratio
- Forward PE
- Price to sales ratio
- EV/EBIT
- Price to free cash flow
- Price to book ratio
- Dividend yield
- Market cap
- Revenue
- EPS
- Free cash flow
- Profit margin
- Shares outstanding
Where it ranks
- #1of 127Consumer staples stocks with the highest profit margins
- #3of 24Consumer staples stocks with the highest dividend yields
- #5of 26Consumer staples stocks with the lowest forward PE
Its groups
About
- Industry
- Tobacco
- Sector
- Consumer Defensive
Valuation data, not investment advice. Prices as of .